147 related articles for article (PubMed ID: 2865350)
1. Ontogeny of food deprivation effects on ornithine decarboxylase: ornithine decarboxylase induction by alpha and beta agonists.
Kuhn CM; McMillian MK; Evoniuk GE; Schanberg SM
J Pharmacol Exp Ther; 1985 Nov; 235(2):361-7. PubMed ID: 2865350
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of ornithine decarboxylase response to adrenergic agonists and glucagon during food deprivation of neonatal rats.
Kuhn CM; McMillian MK; Schanberg SM
J Pharmacol Exp Ther; 1983 Apr; 225(1):50-6. PubMed ID: 6132000
[TBL] [Abstract][Full Text] [Related]
3. Ontogeny of cardiac ornithine decarboxylase and its beta adrenergic responsiveness in the rat.
Miska SP; Kimmel GL; Harmon JR; Webb P
J Pharmacol Exp Ther; 1984 Aug; 230(2):419-23. PubMed ID: 6086887
[TBL] [Abstract][Full Text] [Related]
4. Hepatic cyclic AMP generation and ornithine decarboxylase induction by glucagon and beta adrenergic agonists.
Evoniuk G; Kuhn CM; Schanberg SM
Life Sci; 1985 May; 36(21):2075-83. PubMed ID: 2860551
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
6. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
7. Enhanced ornithine decarboxylase activity of chick muscle cells in culture by beta-adrenergic agonists.
Juráni M; Vaneková M; Vyboh P; Lamosová D
Methods Find Exp Clin Pharmacol; 1996; 18(1):13-7. PubMed ID: 8721251
[TBL] [Abstract][Full Text] [Related]
8. N alpha-acetyl-beta-endorphin stimulates ornithine decarboxylase activity in preweanling rat pups: opioid- and non-opioid-mediated mechanisms.
Bartolome JV; Bartolome MB; Harris EB; Schanberg SM
J Pharmacol Exp Ther; 1987 Mar; 240(3):895-9. PubMed ID: 3559981
[TBL] [Abstract][Full Text] [Related]
9. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat.
Morris G; Slotkin TA
J Pharmacol Exp Ther; 1985 Apr; 233(1):141-7. PubMed ID: 2858576
[TBL] [Abstract][Full Text] [Related]
10. Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adults rats.
Bareis DL; Slotkin TA
J Pharmacol Exp Ther; 1978 Apr; 205(1):164-74. PubMed ID: 633081
[TBL] [Abstract][Full Text] [Related]
11. Role of thyroid hormone in the development of beta adrenergic control of ornithine decarboxylase in rat heart and kidney.
Pracyk JB; Lappi SE; Slotkin TA
J Pharmacol Exp Ther; 1991 Feb; 256(2):757-66. PubMed ID: 1847210
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
Honeysett JM; Insel PA
J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
[TBL] [Abstract][Full Text] [Related]
15. Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria.
Yuan K; Rhee KS; Park WH; Kim SW; Kim SH
Peptides; 2008 Jul; 29(7):1207-15. PubMed ID: 18378355
[TBL] [Abstract][Full Text] [Related]
16. Changes in electrophysiological and mechanical responses of the rat papillary muscle to alpha- and beta-agonist in streptozotocin-induced diabetes.
Kamata K; Satoh T; Tanaka H; Shigenobu K
Can J Physiol Pharmacol; 1997 Jul; 75(7):781-8. PubMed ID: 9315344
[TBL] [Abstract][Full Text] [Related]
17. Effects of ethanol on alpha-adrenergic and beta-adrenergic agonist-stimulated beta-endorphin release and cAMP production in hypothalamic cells in primary cultures.
De A; Boyadjieva NI; Sarkar DK
Alcohol Clin Exp Res; 1999 Jan; 23(1):46-51. PubMed ID: 10029202
[TBL] [Abstract][Full Text] [Related]
18. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
Nakano M; Kanda T; Matsuzaki S; Hasegawa S; Ma H; Imai S; Suzuki T; Kobayashi I
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
[TBL] [Abstract][Full Text] [Related]
19. Role of sympathetic neurons in development of beta-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment.
Hou QC; Baker FE; Seidler FJ; Bartolome M; Bartolome J; Slotkin TA
J Dev Physiol; 1989 Mar; 11(3):139-46. PubMed ID: 2553794
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic glucose: a requirement for neonatal ODC induction by specific hormones.
Evoniuk G; Kuhn C; Schanberg S
Am J Physiol; 1984 Aug; 247(2 Pt 1):E243-50. PubMed ID: 6380309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]